King Pharmaceuticals (KG) announces that the results from a Phase III clinical trial for its ALTACE diuretic combination product will be presented at the ...
... from the Phase III clinical trial evaluating the efficacy and safety of the Company's ALTACE(R) (ramipril) diuretic fixed-dose combination product. ...
all 77 news articles
... Cardizem® a registered trademark of Biovail Corporation; Lovenox® a registered trademark of Sanofi-Aventis and Altace® a registered trademark of King ...